Current use of imatinib in the treatment of chronic myeloid leukemia

被引：0
|
作者：
O'Dwyer, M [1 ]
机构：
[1] Univ Coll Hosp Galway, Dept Hematol, Galway, Ireland
来源：
HAEMATOLOGICA | 2003年 / 88卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：241 / 244
页数：4
相关论文
共 50 条
  • [11] Targeted treatment of chronic myeloid leukemia: role of imatinib
    Tamascar, Ila
    Ramanarayanan, Jeyanthi
    ONCOTARGETS AND THERAPY, 2009, 2 : 63 - 71
  • [12] RESULTS OF CHRONIC MYELOID LEUKEMIA TREATMENT BY IMATINIB IN UKRAINE
    Dyagil, I.
    Dmytrenko, I.
    Minchenko, J.
    Perekhrestenko, T.
    Tretyak, N.
    Fedorenko, V.
    Martina, Z.
    Babkina, N.
    Bebeshko, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 542 - 542
  • [13] Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
    Ramchandren, Radhakrishnan
    Schiffer, Charles A.
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 205 - 214
  • [14] Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia
    Marin, David
    SEMINARS IN HEMATOLOGY, 2010, 47 (04) : 312 - 318
  • [15] Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Ciarcia, Roberto
    Damiano, Sara
    Puzio, Maria Valeria
    Montagnaro, Serena
    Pagnini, Francesco
    Pacilio, Carmen
    Caparrotti, Giuseppe
    Bellan, Cristiana
    Garofano, Tiziana
    Polito, Maria Sole
    Giordano, Antonio
    Florio, Salvatore
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (03) : 680 - 687
  • [16] MicroRNA improves the efficacy of imatinib on the treatment of chronic myeloid leukemia
    Yi, Bin
    Ma, Ruixia
    Feng, Xiangling
    Xing, Zhiwei
    Zhang, Xiaoguo
    Piazza, Gary
    Xi, Yaguang
    CANCER RESEARCH, 2014, 74 (19)
  • [17] Tuberculous Lymphadenitis Complicating Imatinib Treatment For Chronic Myeloid Leukemia
    Yaghmour, B.
    Romero-Legro, I.
    Muthiah, M.
    Freire, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [18] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Elias Jabbour
    Jorge Cortes
    Hagop Kantarjian
    Targeted Oncology, 2009, 4 : 3 - 10
  • [19] Comparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Zhang, Bang-Shuo
    Chen, Yong-Ping
    Lv, Jing-Long
    Yang, Yi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (07): : 631 - 634
  • [20] Treatment of chronic myeloid Leukemia with Imatinib IRIS-Study
    Saussele, S.
    Nitschmann, S.
    INTERNIST, 2017, 58 (11): : 1220 - 1221
12345